NAVIGO
Live / Registered — Registered — Section 71 accepted (as of 28 Apr 2025)
What this means for you
Registered since 08 Jan 2019. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 08 Jan 2029: the §71 ten-year affidavit of use).
Record
- Serial number
- 79219910
- Registration number
- 5645889
- Mark type
- Word mark
- Filed
- 08 Sept 2017
- Published for opposition
- 23 Oct 2018
- Registered
- 08 Jan 2019
- Next maintenance filing
- §71 ten-year affidavit of use, due by 08 Jan 2029 (grace period to 08 Jul 2029)
- Attorney of record
- Adam D. Mandell
Goods and services
- Class 001 — Chemicals: Chemical, biological, analytical, and/or chromatographic substances, active agents, and/or compositions, namely, polypeptides, proteins or peptides in raw form for scientific research, namely, for analysis of polypeptide, protein and peptide interaction, all of the foregoing not for medical or veterinary use
- Class 005 — Pharmaceuticals: Diagnostic, therapeutic, analytical, biological, chemical, biochemical substances, active agents, and/or compositions, namely, diagnostic preparations for medical [ and veterinary ] use, therapeutic preparations for medical [ and veterinary use, namely, medicated bath preparations, ] pharmaceutical preparations for the medical treatment of cancer, metabolic, inflammatory, skin, eye and cardiovascular diseases, and chemical reagents for medical or veterinary purposes
- Class 042 — Scientific and technological services: Scientific and technological services, namely, scientific research and analysis in the fields of pharmaceutical, diagnostic, analytical or biochemical substances; scientific and technological services, namely, scientific research in the fields of the identification, further development, and use of biochemical, pharmaceutical, analytical and diagnostic products; scientific laboratory services in the fields of molecular biological, biotechnological, biochemical or pharmaceutical products; research and development in the field of medical and veterinary diagnostics and treatment using molecular biological, genetic engineering, biotechnological or biochemical methods, and in the field of identification, screening and development of pharmaceutically active components, and test methods and test kits
Owner
- Navigo Proteins GmbH, Halle, DE
- Navigo Proteins GmbH, DE
- Navigo Proteins GmbH, DE
Prosecution history
- 13 Aug 2026 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 22 Jul 2026 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 21 Jul 2026 — INVALIDATION PROCESSED
- 28 Dec 2025 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 28 Apr 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 28 Apr 2025 — REGISTERED-SEC.71 ACCEPTED
- 28 Apr 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Dec 2024 — TEAS SECTION 71 RECEIVED
- 08 Jan 2024 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 03 May 2019 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 11 Apr 2019 — FINAL DISPOSITION NOTICE SENT TO IB
- 11 Apr 2019 — FINAL DISPOSITION PROCESSED
- 08 Apr 2019 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 08 Jan 2019 — REGISTERED-PRINCIPAL REGISTER
- 23 Oct 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED